Skip to main content
logo
Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,910.00
-390.00 (-4.70%)
At close: Sep 11, 2026

KOSDAQ:014950 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
62,26260,02055,85751,229
Revenue Growth
8.69%7.45%9.04%-
Gross Profit
42,91042,29838,73833,870
Operating Income
1,8233,2733,6782,796
Net Income
-1,498-754.893,5222,969
Earnings Per Share
-170.03-99.50501.00423.00
EPS Growth
--18.44%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
32,34932,07012,9358,766
Total Debt
291.513,01992.71196.52
Net Cash (Debt)
32,05829,05112,8428,570
Net Cash Growth
76.21%126.22%49.85%-
Net Cash Per Share
3639.883829.061826.671220.83

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
1,1982,0774,3852,248
Capital Expenditures
-3,593-3,423-842.32-1,374
Free Cash Flow
-2,395-1,3463,543874.05
Free Cash Flow Growth
--305.32%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
68.92%70.47%69.35%66.11%
Operating Margin
2.93%5.45%6.59%5.46%
Pretax Margin
-2.31%0.08%7.79%6.68%
Profit Margin
-2.40%-1.26%6.31%5.80%
FCF Margin
-3.85%-2.24%6.34%1.71%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
1.282.13--